openPR Logo
Press release

Dengue Fever Treatment Market Anticipated to Reach USD 10.59 Billion, at a Notable 4.06% CAGR by 2034

07-15-2025 11:38 AM CET | Health & Medicine

Press release from: Market Research Future

Dengue Fever Treatment Market

Dengue Fever Treatment Market

Dengue Fever Treatment: Managing Symptoms and Preventing Complications

Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily by Aedes aegypti mosquitoes. It is prevalent in tropical and subtropical regions, especially during and after rainy seasons. While there is no specific antiviral treatment for dengue, supportive care and early intervention play a crucial role in managing the disease and preventing serious complications.

The GMP Storage Market was valued at USD 7.11 billion in 2024 and is projected to witness consistent expansion over the next decade. Forecasts indicate the market will grow from USD 7.40 billion in 2025 to approximately USD 10.59 billion by 2034, reflecting a compound annual growth rate (CAGR) of around 4.06% during the 2025-2034 period. This growth trajectory is fueled by increasing regulatory demands, heightened focus on product safety and integrity, and the expansion of pharmaceutical and biotechnology manufacturing capacities that require compliant storage environments.

Request To Free Sample of This Strategic Report: https://www.marketresearchfuture.com/sample_request/9269

Key Companies in the Dengue Fever Treatment Market Include:

Pfizer
Bharat Biotech
Roche
Regeneron Pharmaceuticals
Johnson and Johnson
AstraZeneca
Valneva
Medigen Vaccine Biologics Corporation
Takeda Pharmaceutical
Merck and Co
AbbVie
GSK
Novartis
Sanofi
Boehringer Ingelheim

Recognizing Dengue Fever
Symptoms of dengue usually appear 4-10 days after the mosquito bite and can last up to a week. Common signs include:

High fever (up to 104°F or 40°C)

Severe headaches

Pain behind the eyes

Joint and muscle pain (often referred to as "breakbone fever")

Nausea and vomiting

Skin rash

Mild bleeding (like nose or gum bleeding, or easy bruising)

In some cases, the disease can progress to severe dengue, also known as dengue hemorrhagic fever or dengue shock syndrome, which can be life-threatening due to internal bleeding, plasma leakage, or organ impairment.

You Can Purchase Complete Report: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=9269

Dengue Fever Treatment Market Segmentation Insights

Dengue Fever Treatment Market Treatment Method Outlook

Supportive Care
Antiviral Drugs
Vaccination

Dengue Fever Treatment Market Route of Administration Outlook

Oral
Intravenous
Intramuscular

Dengue Fever Treatment Market Patient Type Outlook

Adult
Geriatric

Dengue Fever Treatment Market End User Outlook

Hospitals
Clinics
Homecare Settings

Dengue Fever Treatment Market Regional Outlook

North America
Europe
South America
Asia Pacific
Middle East and Africa

Browse In-depth Market Research Report (Pages, Charts, Tables, Figures): https://www.marketresearchfuture.com/reports/gmp-storage-market-37296

Supportive Treatment for Dengue Fever

There is no cure for dengue, and treatment focuses on relieving symptoms and ensuring the patient remains hydrated and monitored for complications. The key components of dengue treatment include:

1. Hydration
Maintaining proper fluid balance is essential.

Oral rehydration solutions (ORS), water, soups, and electrolyte drinks help prevent dehydration.

In severe cases, intravenous (IV) fluid therapy may be necessary.

2. Fever and Pain Management
Paracetamol (acetaminophen) is the recommended medication to reduce fever and alleviate body pain.

Avoid non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or aspirin, as they can increase the risk of bleeding.

3. Monitoring and Observation
Patients should be closely monitored for warning signs such as persistent vomiting, severe abdominal pain, rapid breathing, bleeding gums, or fatigue.

Blood tests to monitor platelet count, hematocrit levels, and liver function are often required during the illness.

4. Rest
Bed rest helps the body recover more effectively.

Patients should avoid strenuous activities until they are fully recovered.

Hospitalization Criteria
Hospitalization is recommended if the patient shows:

Signs of severe dehydration

Bleeding tendencies or low platelet counts

Severe abdominal pain or persistent vomiting

Sudden drop in blood pressure (shock symptoms)

Preventive Measures
While treatment is supportive, preventing dengue is crucial, especially during outbreaks. Key steps include:

Eliminating mosquito breeding grounds (stagnant water)

Using mosquito repellents and nets

Wearing long-sleeved clothing

Installing screens on windows and doors

In some countries, the Dengvaxia vaccine is approved for individuals who have had a prior dengue infection, as it can help reduce the risk of severe dengue in future exposures.

Related Report:

India Ehr Emr Market : https://www.marketresearchfuture.com/reports/india-ehr-emr-market-44691
Us Global Ehr Emr Market : https://www.marketresearchfuture.com/reports/us-global-ehr-emr-market-13352
Italy Healthcare Revenue Cycle Management Market : https://www.marketresearchfuture.com/reports/italy-healthcare-revenue-cycle-management-market-44710
Us Healthcare Revenue Cycle Management Market : https://www.marketresearchfuture.com/reports/us-healthcare-revenue-cycle-management-market-44709
Us Hospital Bed Market : https://www.marketresearchfuture.com/reports/us-hospital-bed-market-15671
Us Intravenous Solution Market : https://www.marketresearchfuture.com/reports/us-intravenous-solution-market-13402
China Wound Care Market : https://www.marketresearchfuture.com/reports/china-wound-care-market-44684
France Wound Care Market : https://www.marketresearchfuture.com/reports/france-wound-care-market-44681
Germany Wound Care Market : https://www.marketresearchfuture.com/reports/germany-wound-care-market-44679
Italy Wound Care Market : https://www.marketresearchfuture.com/reports/italy-wound-care-market-44683

Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com

About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dengue Fever Treatment Market Anticipated to Reach USD 10.59 Billion, at a Notable 4.06% CAGR by 2034 here

News-ID: 4104465 • Views:

More Releases from Market Research Future

Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Due To Due to increasing popularity of Denim jeans, Denim jackets, and other denim apparel.
Denim Market Size By 2035 with 5.25 USD Billion in 2025 to 132.4 USD Billion, Du …
Denim Market Size Grow at a 75.25 USD Billion in 2025 to 132.4 USD Billion by 2035, CAGR of 5.81% By 2025 - 2035 Global Denim Market is entering a new phase of transformation as consumer demand, fashion cycles, and sustainable innovation continue to reshape the industry. Denim, once considered a classic wardrobe staple, has evolved into a versatile, fashion-driven category supported by innovations in fabric technology, eco-friendly production, and shifting
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% CAGR from 2024
Humanoid Robots Market Size to Reach USD 13.8 Billion by 2032, Growing at 50.2% …
The global Humanoid Robots Market is projected to reach USD 13.8 Billion by 2032, growing at a robust CAGR of 50.2% during the forecast period from 2024 to 2032. Driven by advancements in artificial intelligence, machine learning, and machine vision, humanoid robots-designed with human-like characteristics-are witnessing widespread adoption across healthcare, education, space exploration, and service industries. These robots are enhancing operational efficiency, performing complex tasks, and improving customer engagement across multiple
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.83 Billion by 2035
Vertical Farming Market Expansion: USD 9.023 Billion in 2025 Growing to USD 58.8 …
The Vertical Farming Market was estimated at USD 7.48 Billion in 2024 and is projected to grow from USD 9.023 Billion in 2025 to USD 58.83 Billion by 2035, exhibiting a robust CAGR of 20.62% during the forecast period from 2025 to 2035. Driven by increasing demand for sustainable agriculture, urbanization, and technological advancements in controlled-environment farming, vertical farming solutions are seeing widespread adoption across commercial, industrial, and urban agriculture sectors. Key
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to Hit USD 476,019.67 Million by 2035
Robotics Market Trends and Forecast: USD 74,120.70 Million in 2024 Expected to H …
The Robotics Market was valued at USD 74,120.70 Million in 2024 and is projected to reach USD 476,019.67 Million by 2035, growing at a robust CAGR of 18.4% during the forecast period from 2024 to 2035. Driven by advancements in medical robots, growing industrial robotics adoption, and the development of AI technologies, robotics solutions are witnessing widespread adoption across healthcare, manufacturing, logistics, and service sectors. Despite challenges like high initial costs

All 5 Releases


More Releases for Dengue

Key Trend Reshaping the Dengue Treatment Market in 2025: Innovative Drug Deliver …
Which drivers are expected to have the greatest impact on the over the dengue treatment market's growth? The escalation in cases of dengue is projected to stimulate the expansion of the market for dengue treatments. Dengue is a viral infection transmitted by mosquito bites, causing symptoms akin to the flu and can escalate to intense complications if not treated. The escalation is primarily due to progressing urbanization, climate alterations favourable to
Key Dengue Vaccine Market Trend for 2025-2034: Advancements In Dengue Tetravalen …
What Is the Future Outlook for the Dengue Vaccine Market's Size and Growth Rate? In the past few years, the dengue vaccine market has experienced significant growth. From $0.64 billion in 2024, it is projected to reach $0.72 billion in 2025, marking a compound annual growth rate (CAGR) of 12.4%. This notable expansion during the historical period can be credited to factors such as an increase in travel and urbanization trends,
Dengue Vaccine Market : An Detailed Overview
Introduction: Dengue fever is a mosquito-borne viral infection caused by the dengue virus, transmitted primarily through Aedes aegypti and Aedes albopictus mosquitoes. Affecting millions globally each year, dengue has become a significant public health concern, especially in tropical and subtropical regions. The development of dengue vaccines represents a groundbreaking advancement in preventing the disease, reducing its associated healthcare costs, and controlling outbreaks. With increasing awareness and investments in immunization programs, the
Dengue Vaccine Market : An Overview
Introduction: Dengue fever is a mosquito-borne viral infection that has become a significant public health challenge in tropical and subtropical regions. The disease is caused by the dengue virus, which is transmitted primarily by Aedes aegypti mosquitoes. With approximately 390 million infections annually, dengue fever places a substantial burden on healthcare systems and economies worldwide. Efforts to mitigate this burden have led to the development of dengue vaccines, designed to prevent
"Rising Incidence of Dengue Fever Propels Dengue Virus Diagnostic Tests Market T …
According to WHO, dengue affects about 50-100 million people worldwide, annually. It is a vector-borne highly communicable disease. This report discusses the diagnostic tests used to confirm the presence of dengue in one individual. It is true that the growth of the global dengue virus diagnostic tests market is primarily driven by an increase in the incidence of dengue fever, which is a mosquito-borne viral infection that can cause severe flu-like
Dengue Vaccines Market 2021 | Detailed Report
Dengue Vaccines Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027. Get Free Sample PDF (including full TOC, Tables and Figures) of Dengue Vaccines Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4644240 The report provides a comprehensive analysis of company profiles listed below: - Sanofi - Takeda Dengue Vaccines Market Segment by